Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends

Standard

Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends. / Sales, Arthur H A; Beck, Jürgen; Schnell, Oliver; Fung, Christian; Meyer, Bernhard; Gempt, Jens.

In: J CLIN MED, Vol. 11, No. 18, 5354, 13.09.2022.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

Sales, AHA, Beck, J, Schnell, O, Fung, C, Meyer, B & Gempt, J 2022, 'Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends', J CLIN MED, vol. 11, no. 18, 5354. https://doi.org/10.3390/jcm11185354

APA

Sales, A. H. A., Beck, J., Schnell, O., Fung, C., Meyer, B., & Gempt, J. (2022). Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends. J CLIN MED, 11(18), [5354]. https://doi.org/10.3390/jcm11185354

Vancouver

Bibtex

@article{9d38974bd09441259af7be3a43f55111,
title = "Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends",
abstract = "Glioblastoma (GBM) is a highly aggressive disease and is associated with poor prognosis despite treatment advances in recent years. Surgical resection of tumor remains the main therapeutic option when approaching these patients, especially when combined with adjuvant radiochemotherapy. In the present study, we conducted a comprehensive literature review on the state-of-the-art and future trends of the surgical treatment of GBM, emphasizing topics that have been the object of recent study.",
author = "Sales, {Arthur H A} and J{\"u}rgen Beck and Oliver Schnell and Christian Fung and Bernhard Meyer and Jens Gempt",
year = "2022",
month = sep,
day = "13",
doi = "10.3390/jcm11185354",
language = "English",
volume = "11",
journal = "J CLIN MED",
issn = "2077-0383",
publisher = "MDPI AG",
number = "18",

}

RIS

TY - JOUR

T1 - Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends

AU - Sales, Arthur H A

AU - Beck, Jürgen

AU - Schnell, Oliver

AU - Fung, Christian

AU - Meyer, Bernhard

AU - Gempt, Jens

PY - 2022/9/13

Y1 - 2022/9/13

N2 - Glioblastoma (GBM) is a highly aggressive disease and is associated with poor prognosis despite treatment advances in recent years. Surgical resection of tumor remains the main therapeutic option when approaching these patients, especially when combined with adjuvant radiochemotherapy. In the present study, we conducted a comprehensive literature review on the state-of-the-art and future trends of the surgical treatment of GBM, emphasizing topics that have been the object of recent study.

AB - Glioblastoma (GBM) is a highly aggressive disease and is associated with poor prognosis despite treatment advances in recent years. Surgical resection of tumor remains the main therapeutic option when approaching these patients, especially when combined with adjuvant radiochemotherapy. In the present study, we conducted a comprehensive literature review on the state-of-the-art and future trends of the surgical treatment of GBM, emphasizing topics that have been the object of recent study.

U2 - 10.3390/jcm11185354

DO - 10.3390/jcm11185354

M3 - SCORING: Review article

C2 - 36143001

VL - 11

JO - J CLIN MED

JF - J CLIN MED

SN - 2077-0383

IS - 18

M1 - 5354

ER -